Noseworthy John H 4

What Happened
John H. Noseworthy, a director of UnitedHealth Group (UNH), was granted 206 deferred stock units on July 1, 2026. The reported acquisition price is $0.00 (no cash paid); the transaction is an award of deferred stock units issued as director compensation rather than an open‑market buy or sale.

Key Details

• Transaction date: 2026-07-01 (Form 4 filed 2026-07-06).
• Transaction type: Award/Grant (code A) of 206 deferred stock units; reported price $0.00.
• Shares owned after transaction: Not specified in the filing.
• Footnote: These are deferred stock units granted as regular quarterly director compensation. They vest immediately but must be retained until the director leaves the Board. (Footnote F1)
• Filing timeliness: Form filed within days after the report date; no late‑filing indication in the filing.

Context
Deferred stock units are a non‑cash form of compensation for directors. They are not a purchase (which might signal a personal investment) nor a sale; because the units must be held until board service ends, this award is routine director pay and should not be interpreted on its own as a market sentiment indicator.